trending Market Intelligence /marketintelligence/en/news-insights/trending/pglahcgyjsavwarfe0rpda2 content esgSubNav
In This List

Canada's Crescita Therapeutics completes C$3.7M rights offering

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Canada's Crescita Therapeutics completes C$3.7M rights offering

Ontario-based Crescita Therapeutics Inc. completed a rights offering to raise C$3.7 million in gross proceeds.

The company, which develops treatments for skin diseases, will issue 7,001,603 common shares priced at 53 Canadian cents apiece.

The company plans to use the net proceeds for working capital and for business development initiatives.